Copyright
©The Author(s) 2020.
World J Hepatol. Oct 27, 2020; 12(10): 738-753
Published online Oct 27, 2020. doi: 10.4254/wjh.v12.i10.738
Published online Oct 27, 2020. doi: 10.4254/wjh.v12.i10.738
Figure 2 Eighty-three-year old male with nonalcoholic steatohepatitis related cirrhosis presented with a 3.
5 cm mass demonstrating arterial phase hyperenhancement (APHE) (A) and “washout” (B), compatible with an LR-5 hepatocellular carcinoma; C: Pre-contrast T1 images 6 mo post microwave ablation demonstrate a hypointense nodular area along the anterior margin of the ablation cavity, with thick irregular nodular APHE on arterial phase (D) and “washout” and “capsule” on portal venous phase (E), LR-TR Viable.
- Citation: Aslam A, Do RKG, Kambadakone A, Spieler B, Miller FH, Gabr AM, Charalel RA, Kim CY, Madoff DC, Mendiratta-Lala M. Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directions. World J Hepatol 2020; 12(10): 738-753
- URL: https://www.wjgnet.com/1948-5182/full/v12/i10/738.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i10.738